Press "Enter" to skip to content

ICMR to test efficacy of two medicines for tackling drug-resistant TB

New Delhi: The Indian Council of Medical Research (ICMR) is planning to test the efficacy of two medicines — Metformin and Bedaquiline Delaminate — for tackling the drug-resistant tuberculosis.

Metformin is widely used to treat type-II diabetes. ICMR now plans a clinical trial to examine its effectiveness in fighting the TB microbe following encouraging scientific results from Indian biologists, reports Deccan Herald.

Bedaquiline, which received the US Food and Drug Administration’s approval in 2012 for the treatment of drug-resistant TB cases, is yet to be used in India’s public-funded national TB control programme.

The Metformin trial is expected to start in a couple of months, while the Bedaquiline trial may take about six months to kick off, according to ICMR director general Dr Soumya Swaminathan.

One Comment

  1. shivani gour shivani gour Tuesday, May 30, 2017

    90 percent of population grows up deficient in Vitamin D3, which is involved in keeping our immune system intact. Yet no study mentions this as its not lucrative enough and plus supplementation will genuinely improve health )Which may not be the real aim of those who fund)

Leave a Reply

Your email address will not be published. Required fields are marked *